Ninth Triangle Ride For Kids® A Roaring Success

Bayer CropScience raises $25,685 For Pediatric Brain Tumor Foundation®

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
The money that we raise helps the Pediatric Brain Tumor Foundation provide support for patients and their families, and makes it possible to perform research that improves lives and will hopefully one day lead to a cure for this disease.

RESEARCH TRIANGLE PARK, NC (PRWEB) May 11, 2012

“Born-to-be-wild” Bayer CropScience employees, families and retirees donned their helmets and revved up their motorcycles on Sunday, May 6 in the ninth Triangle Ride for Kids® to benefit the Pediatric Brain Tumor Foundation®, an organization dedicated to supporting research on the cause and cure of childhood brain tumors. Hundreds of riders took to the road on the 50-mile trip from a Jordan Lake State Recreation Area in Apex, N.C. to Pittsboro, N.C. and back to celebrate the lives of brave children who are battling or have survived brain tumors.

This year, Bayer CropScience raised $25,685 and was the top fundraising team for the third year in a row. Each company participant showed dedication to changing the outlook and creating a better tomorrow for those suffering from pediatric brain tumors and the company’s donation contributed to the Triangle Ride for Kids® raising a total of $92,700. Funds were raised by Bayer CropScience through donation of lunch proceeds, silent and live auctions, and a “bring your child to work” day bake sale hosted by the children of employees, along donations from generous employees, friends and family.

“It is all about the children and that is why we are here today,” said Ashley Holland, Bayer CropScience Ride for Kids® committee co-chair, during the Celebration of Life on Sunday, May 6 following the motorcycle ride. “The money that we raise helps the Pediatric Brain Tumor Foundation provide support for patients and their families, as well as scholarships for survivors, and makes it possible to perform research that improves lives and will hopefully one day lead to a cure for this disease.”

The Pediatric Brain Tumor Foundation® Institute at Duke University in Durham, N.C. is one of three in the foundation’s Institute Program and has received over $12 million in grants since 2003.

For more information on Bayer CropScience, visit http://www.bayercropscience.us or check out the newly launched Bayer CropScience social media hub, connect.bayercropscience.us.

About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience, a subgroup of Bayer AG with annual sales of EUR 7.255 billion (2011), is one of the world’s leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of 21,000 and is represented in more than 120 countries. This and further news is available at: http://www.press.bayercropscience.com

Contact:
Media can utilize the hotline at 1-866-99-BAYER, or contact

Beth Roden
External Communications Lead
Bayer CropScience
Tel: (919) 549-2030
Email: beth(dot)roden(at)bayer(dot)com
Twitter: bayer4cropus
(USA-BCS-2012-0209)

©2012 Bayer CropScience LP, 2 T.W. Alexander Drive, Research Triangle Park, NC 27709. Always read and follow label instructions. Bayer (reg’d), the Bayer Cross (reg’d) are trademarks of Bayer. For additional product information call toll-free 1-866-99-BAYER (1-866-992-2937) or visit our Web site at http://www.BayerCropScience.us.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at http://www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.